NASDAQ:IDRA - Idera Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$3.00 +0.36 (+13.64 %)
(As of 02/21/2019 12:31 PM ET)
Previous Close$2.64
Today's Range$2.59 - $3.09
52-Week Range$2.25 - $17.12
Volume475,600 shs
Average Volume375,499 shs
Market Capitalization$81.54 million
P/E Ratio-0.89
Dividend YieldN/A
Beta2.64

Analyst Ratings

Idera Pharmaceuticals (NASDAQ:IDRA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Idera Pharmaceuticals in the last 12 months. Their average twelve-month price target is $22.50, suggesting that the stock has a possible upside of 650.00%. The high price target for IDRA is $32.00 and the low price target for IDRA is $14.00. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $22.50$22.50$22.50$25.50
Price Target Upside: 650.00% upside484.42% upside219.60% upside181.15% upside

Idera Pharmaceuticals (NASDAQ:IDRA) Consensus Price Target History

Price Target History for Idera Pharmaceuticals (NASDAQ:IDRA)

Idera Pharmaceuticals (NASDAQ:IDRA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/17/2018WedbushReiterated RatingOutperform ➝ PositiveHighView Rating Details
10/22/2018HC WainwrightReiterated RatingBuy$18.00HighView Rating Details
9/24/2018BarclaysInitiated CoverageOverweight ➝ Overweight$14.00HighView Rating Details
8/15/2018JPMorgan Chase & Co.Initiated CoverageOverweight$15.00HighView Rating Details
6/13/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$40.00 ➝ $32.00LowView Rating Details
6/13/2018JMP SecuritiesLower Price TargetOutperform ➝ Positive$64.00 ➝ $32.00LowView Rating Details
9/12/2017Piper Jaffray CompaniesReiterated RatingBuy$32.00LowView Rating Details
(Data available from 2/21/2017 forward)
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: Intrinsic Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel